Biohaven (BHVN) logo

Biohaven (BHVN) stock

$13.82
-1.78%

Medicines in development, worth $2.1BSmall-cap biotech

Quality Score
2
Below Average
In its industry
#95of 270
Checks firing
3of 14
Trending up
From 52-week high
-24.2%
under its best in a year

BHVN's Quality Score was unchanged on Fri, Nov 13, at 2.

Follow BHVN's trial news. Pro members can get an alert when Biohaven files news, and see its trials, share raises, and its CEO's filings.

Get an alert when BHVN files news on its trialsSee it live, free until tomorrow morning. No account. No card. Then keep going with a free account.Then 7 days of Pro free, with a card.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Next2H 2026“In epilepsy, RISE 3 topline data for our Kv7 activator opakalim remain on track for the second half of 2026…”Trial data · SEC filing · Oct 29
Cash$161M, about 1 quarter at the last year's spendingOn Sep 30

Why BHVN rose on Oct 22

Up 25% on Oct 22, and still 18% over its Oct 21 close.

“Biohaven's Troriluzole NDA Accepted For FDA Review; Decision In Q1 2027.”

RTTNews and 1 more outlet reported that day

Sources: Price history, Oct 22, 2026; RTTNews, Oct 22, 2026

1 more reason, free with an account →1 more reason why BHVN rose on Oct 22, from its filings, with the timeline and its peers, for Pro members.

Key facts on BHVN

Key facts on BHVN
Holding it back42.7% more shares than a year ago
Latest filing8-K, Oct 29 Reported its quarterly results
1 more reason behind BHVN's 2, free with an account →3 more reasons behind BHVN's 2, for Pro members.

BHVN in the news

Big story

Thu Oct 22: FDA

FDA accepts Biohaven's resubmitted troriluzole NDA for SCA with Q1 2027 goal date

BHVN closed +25.0% that day on 10.8x normal volume.

Reported by allsci · covered by 3 outlets

Get an alert on BHVN's next big story →

Outlet counts from the GDELT Project. The move is what BHVN did that session, not a claim about why.

What's next

Wed Nov 18: AACR-NCI-EORTC (ENA) International…Industry event · date confirmed.

Expected to report Mon Mar 1, after the close

After its last 4 reports it closed -5.2% on average, higher 0 of 4 times.

Cash$161M, about 1 quarter at the last year's spendingOn Sep 30

BHVN catalysts

Coming up

7 more coming up and 8 past catalysts since 2022, with sizes and sources, for Pro members.

What's next for BHVN, and how long its cash lasts

Next step the company has named

2H 2026“In epilepsy, RISE 3 topline data for our Kv7 activator opakalim remain on track for the second half of 2026, and we are working to complete an additional nonclinical safety package and look…”Trial data · SEC filing · Oct 29

What it means: the first look at a trial’s main results, as the company reports them.

A trial underway
RISE 2Phase 2/3 · Active · 390 people · main data estimated Dec 2026 · NCT06132893

12 more trials, 1 with data due this year, 5 more milestones and 41 filings, for Pro members.

Cash runway Sep 30 balance sheet

About 1 quarter

$161M in cash and short-term investments, at its spending over the last year

What it means: how long the cash would last at the same pace, before any new money.

For Pro members: the cash used each quarter, and the math.

Dilution on the horizon

  • Shelf registration (S-3ASR, filed May 4, 2026)
  • At-the-market share sales program (S-3ASR, filed May 4, 2026)

For Pro members: 2 raises and their amounts, and the share count against a year ago.

Insiders

An officer, George C. Clark, bought 17,000 shares on Nov 17, 2025.

From Form 4: open-market buys and sales only.

For Pro members: every trade, and Vlad Coric’s 5 filings and quotes.

Get an alert when BHVN files news on its trialsA free account. No card.Pro, 7 days free with a card.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

12 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 150 dates, ranked →

Why BHVN scores 2

Below Averagefor quality, not price, 3 of 14 chart checks firingWhat the Quality Score means

  • +3Chart checks 3 of 14 firing right now, one point each
  • +2Run-up 58% over 6 months
  • Long-term trend adds
  • Dilution subtractsNew shares over the year: -1 at 10% more, -2 at 25% more.
  • Volatility subtractsA daily range of 5% or more with nothing behind it (no profit or cash flow, sales shrinking, or 10% more shares outstanding with no free cash flow): -1, or -2 from 8%.
  • Cash flow subtracts-1 when free cash flow over the last four quarters is negative.

No effect today: Size, Profit, Growth, Persistence, and News.

What every line is worth, and the reason behind it, on BHVN and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 5:08 AM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Alert me when BHVN's Quality Score turns up

A free account. No card.Pro, 7 days free with a card.

How BHVN ranks in Biotech

BHVN is #95 of 270 by Quality Score.

How BHVN ranks in Biotech
RankStockQuality Score
95Biohaven (BHVN) logoBHVNBiohaven2

Share count against a year before: BHVN +43%, OLMA +18%, VIR +22%, LXRX +22%.

More in Biotech

When does BHVN report earnings, and what happens after?

Expected to report Mon Mar 1, after the close (in 105 days).

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What BHVN reported on Oct 29, 2026

The quarter

A loss of $0.86 a share, from $1.64.

“The decrease of $39.3 million was primarily due to decreases in direct program spend and preclinical spend in 2026 as compared to the same period in the prior year.”

The quarter that ended Sep 30, from the company's press release

The press releaseThe filing on EDGAR

Where the sales came from

BHVN's results filing gives no sales by line in a table we read.

The outlook

No outlook figures read from this release.

In the company's words

  • “The decrease of $3.6 million was primarily due to decreased employee costs, including non-cash share-based compensation expense.”

From its results filing (SEC filing · Oct 29)

The numbers

Market value
$2.1B
today
Free cash flow
-$473M
last 12 months

No analyst estimates on Breakaway: every figure here is filed.

The whole report on BHVN: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.

Close after the report, last 3

-4.2%-0.3%-6.5%
May 4Aug 10Oct 29
ReportedGapReaction5
days
Oct 29, 2026After close-6.3%-6.5%-15.7%
Aug 10, 2026After close-3.7%-0.3%-0.6%
May 4, 2026After close+0.1%-4.2%-10.4%

BHVN closed higher after 0 of its last 4 reports.

All 4 reports, and BHVN's Quality Score going into each

BHVN has 3 of 14 chart checks firing

Volume1 of 3 shown
Tight range1 of 3 shown
Buying1 of 3 shown
The other 10 checks on BHVN, and all 14 on every stock.Get in free →

BHVN RSI on Nov 13: 47.8, above its 50-day and 200-day averages

Not scored

RSI 47.8, MACD below signal, above both averages. Not scored.

The deep dive on BHVN

5 more findings on BHVN, each with its source, for Pro members.

BHVN share count over time

43% more shares than a year earlier.

Weighted shares, quarter to Sep 30, 2026, both from one filing

Shares of BHVN outstanding, as filed
Shares
outstanding
As
of
151.1MOct 26, 2026
151MAug 6, 2026
150.6MApr 30, 2026
150.4MFeb 26, 2026
Offerings, shelves, and splits of BHVN, from its filings
From its
filings
Filed
Registered shares for a later sale (S-3ASR)May 4, 2026
Set up an at-the-market program for up to $300M of shares, about 14% of its market valueAug 16, 2024
Priced a sale of sharesApr 19, 2024

BHVN's officers and directors

Officers and directors with a Form 4 in the last 12 months.

See insider trades by person

About Biohaven

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

274 employeesNew Haven, CTbiohaven.com

Here is what Pro members see.

  • The same page for Pro members, on Microsoft

    Its Quality Score and rank, the line that drives it, and the live price.

  • The full chart

    A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.

  • Every line of the score

    Price action, the company, and signals, each with its points, on BHVN and every other stock.

  • FDA dates, counted down

    Each date in the company's words, its cash against the date, and an optional alert before it.

  • CEOs buying their own stock

    Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.

  • Congress trades

    A member's trades, newest first, each with its amount. Sort and filter the whole list.

  • 14 chart checks, read for you

    The ones firing on the stock, each in plain words, its rule a tap away.

  • Earnings, week by week

    Who reports each day, and how each stock took its last four reports.

  • The market map

    Every stock a box, colored by its Quality Score.

  • Themes, ranked live

    Each theme's stocks ranked by Quality Score, live. Here, AI chips.

  • The top 10, every day

    The ten highest Quality Scores at each close, kept day by day, week by week.

  • Optional alerts, your way

    Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.

  • Your watchlist, scored

    Your stocks by Quality Score, today's move, or name.

  • On your phone and your laptop

    The same account and watchlist on both, each laid out for its screen.

  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

  • What would turn BHVN's score around: 7 things
  • 6 more filings explained, a plain line each
  • Real-⁠time prices, no delay
See BHVN's 14 chart checks

See it live, free until tomorrow morning. No account. No card. Then keep going with a free account.Then 7 days of Pro free, with a card.

Straight AnswersStraight Answers

As of Nov 16, 2026: BHVN's Quality Score is 2 (Below Average), #95 of 270 in Biotech.

What does BHVN's Quality Score say?

BHVN scores 2 today, which Breakaway calls Below Average. It is #95 of 270 in Biotech by Quality Score, with 3 of 14 chart checks firing. Up 25% on Oct 22, and still 18% over its Oct 21 close. Cash lasts about 1 quarter at its spending (to Sep 30). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is BHVN's Quality Score?

BHVN scores 2 today, which Breakaway calls Below Average (0 to 5). That is #95 of 270 in Biotech by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind BHVN's 2.

When does BHVN report earnings?

Expected to report Mon Mar 1, after the close, a date Breakaway expects from the company's usual timing; the company has not confirmed it. BHVN closed higher after 0 of its last 4 reports. Past behavior, not a forecast.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

Every US stock, ranked live.

Insider and Congress trades, the chart, and the financials, in one score.

See all 3,145 stocks ranked

See it live, free until tomorrow morning. No account. No card. Then keep going with a free account.Then 7 days of Pro free, with a card.

What's next for Biohaven: from its SEC filings and ClinicalTrials.gov, the company's words, the registry's dates, and arithmetic, not a forecast. Companies often miss the dates they set.

The moves after past earnings reports are past behavior, not a forecast.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9, 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.